These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6364088)

  • 1. Cephalexin in lower respiratory tract infections.
    Raff MJ
    Postgrad Med J; 1983; 59 Suppl 5():32-9. PubMed ID: 6364088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cephalexin in the treatment of upper respiratory tract infections.
    Disney FA
    Postgrad Med J; 1983; 59 Suppl 5():28-31. PubMed ID: 6364087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-lactam antibiotics in lower respiratory tract infections.
    Schreiner A
    Scand J Infect Dis Suppl; 1984; 42():129-34. PubMed ID: 6597558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cephalexin in lower respiratory infections.
    Practitioner; 1972 Mar; 208(245):421-3. PubMed ID: 4554484
    [No Abstract]   [Full Text] [Related]  

  • 5. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of acute bacterial infections with cefaclor in a pediatric population: an open assessment.
    Iancu TC; Sinoff G
    Isr J Med Sci; 1983 Nov; 19(11):998-1000. PubMed ID: 6662693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cephalexin: clinical effectiveness in geriatric patients.
    Smith IM
    Geriatrics; 1977 Mar; 32(3):91-5, 99. PubMed ID: 844692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
    White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B
    J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
    Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS
    Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cepharadine and cephalexin in the treatment of respiratory and urinary tract infections.
    Mogabgab WJ
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):421-32. PubMed ID: 4284
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacology of cephalexin.
    Griffith RS
    Postgrad Med J; 1983; 59 Suppl 5():16-27. PubMed ID: 6364086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing acute lower respiratory tract infections in an era of antibacterial resistance.
    Volturo GA; Low DE; Aghababian R
    Am J Emerg Med; 2006 May; 24(3):329-42. PubMed ID: 16635707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to the effective management of respiratory tract infections in the community.
    Saginur R
    Infection; 2001 Dec; 29 Suppl 2():3-10. PubMed ID: 11785853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of pulmonary infections with cephalexin (author's transl)].
    Götz M; Klabuschnigg A
    Padiatr Padol; 1978; 13(2):221-5. PubMed ID: 643299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistant Haemophilus influenzae from respiratory tract infection in a tertiary care hospital in north India.
    Nag VL; Ayyagari A; Venkatesh V; Ghar M; Yadav V; Prasad KN
    Indian J Chest Dis Allied Sci; 2001; 43(1):13-7. PubMed ID: 11370501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin.
    Cantón R; Lode H; Graninger W; Milkovich G
    Int J Antimicrob Agents; 2006 Sep; 28 Suppl 2():S115-27. PubMed ID: 16904873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections.
    Sader HS; Jones RN
    Expert Rev Anti Infect Ther; 2007 Feb; 5(1):29-43. PubMed ID: 17266451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cephalexin in pulmonary infections in children].
    Paschetta G; De Biasi V
    Minerva Pediatr; 1971 Dec; 23(49):2065-71. PubMed ID: 5131194
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy of cefadroxil in acute and chronic bacterial infections of the respiratory tract].
    Nosenzo M; Razzetti A; Delle Piane M; Faravelli B; Suffritti G
    Clin Ter; 1983 Mar; 104(5):383-9. PubMed ID: 6342913
    [No Abstract]   [Full Text] [Related]  

  • 20. [Absorption, elimination and therapeutic effectiveness of a new antibiotic and mucolytic combination for oral administration].
    Silvia G; Giambrone F; Battaglia E; Romano M
    G Clin Med; 1981 Mar; 62(3):209-27. PubMed ID: 7250579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.